Analyst Ratings for CME Group Inc. Cl A (CME)

Updated: 2017-07-28

CME Group Inc. Cl A (NASDAQ:CME) was awarded an average rating of Overweight from investment analysts following the stock. CME had previously received a consensus rating of Overweight a month ago.

16 analysts issued ratings on the stock, where 9 gave CME a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 1 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

Many analysts weighed in on price targets for CME. The most optimistic price target was 140, which equates to a potential upside of 15.3 percent. The lowest price target was 106, implying a possible loss of -12.7 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of -1.23 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -3.23 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -0.51 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 2 analysts increased their quarterly estimates, while 5 analysts made negative revisions. During this time, 4 analysts made positive revisions in their estimates for this fiscal year's earnings, while 4 analysts decreased their estimates.

CME has an estimated earnings growth rate of 4.99 percent as forecasted by analysts. The PEG ratio of a stock is another value frequently studied by investors. Smaller PEG ratios are desirable, because that is often interpreted as the company being fairly priced relative to its growth rate. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of CME is 5.27.

In the trailing 52-weeks, CME hit 127.96 at the highest peak, while it's lowest trading point was 98.95. The current market price is above the trailing year's low by 22.71 percent, and 5.11 percent lower than its 52-week high. CME has a price/earnings ratio of 26.3. Investors typically compare the P/E ratio to a company's peers in the industry. The CME value stock report compares CME to some of its peers using value stock charts. The market cap of CME is $41.24 billion. CME is estimated to release their earnings results for the quarter on 0000-00-00, days from today.